A 10-weeks, randomized, placebo-controlled, double-blind trial demonstrated that NMN (250 mg/day) supplementation only increased muscle insulin sensitivity, insulin signaling, and muscle remodeling in women with prediabetes who are overweight or obese (NCT03151239) (Yoshino et al., 2021). This evidence concerns the gene INS and prediabetes syndrome.